A high IGF-I to IGFBP-3 ratio was linked with an increased risk of prostate cancer and could be used as a predictor for prostate cancer development ( 6 The link between IGF and prostate cancer metastasis Bones are the most frequent metastatic site for prostate cancer, with 7080% of patients experiencing skeletal metastases
But those studies, McGuire says, dont have a lot of evidence behind them, and if you look on Reddit or other places where people are talking about it, he says, it appears that most people are recommending repeated doses
47.Chung H.K., Kang B., Lee J.H., Shim J.Y., Park S., Lee S.H., et al
Your doctor will give you a blood test about 6 to 8 weeks after you begin taking the medicine, adjusting your dose if needed
One of the most remarkable findings about BPC-157 involves its systemic migration capability